| Pathway
|
Gap Junction Assembly
|
|
Metastatic Colorectal Cancer Overview
|
|
Effect of NO on Vasodilation and Triptans on Vasoconstriction in Familial Hemiplegic Migraine
|
|
Activation of eNOS (NOS3) via Prostaglandin E2 and Histamine in Familial Hemiplegic Migraine
|
|
Congenital Secondary (Central) Hypothyroidism
|
|
Congenital Hypothyroidism Due to Thyroid-Stimulating Hormone Resistance
|
|
Graves Ophthalmopathy
|
|
Thyroid Dysfunction in Graves Disease
|
|
Cardiovascular Effects of Hyperthyroidism
|
|
Effects of Hyperthyroidism on Bone Remodeling
|
|
Primary Overt Hypothyroidism Overview
|
|
Hypothyroidism Influence on Hypothalamic Release of Thyrotropin-Releasing Hormone
|
|
Overt Hypothyroidism Influence on Thyroid-Stimulating Hormone Secretion
|
|
Central Hypothyroidism Overview
|
|
Tertiary Hypothyroidism Overview
|
|
MITF as a Regulator of Melanoma Cell Development
|
|
Melanoma Overview
|
|
NO Synthesis in Early Vasospasm
|
|
Contraction due Vasospasm
|
|
CFTR-Related Ion-Channel Dysfunction in Cystic Fibrosis Airway Epithelium (Class III Mutations)
|
|
CFTR Up-regulates the Oxidative Stress in Airway Epithelium in Cystic Fibrosis
|
|
The Role of CFTR in Sperm Capacitation and Acrosome Reaction
|
|
CFTR Expression in Epithelial Cells (Class I Mutations)
|
|
Airway Epithelial Cell Dysfunction in Cystic Fibrosis (Overview)
|
|
Endothelial Cell Dysfunction in Pulmonary Arterial Hypertension
|
|
FSH Action in Polycystic Ovary Syndrome
|
|
Impaired Steroidogenesis in Polycystic Ovary Syndrome
|
|
Block of Ovulation in Polycystic Ovary Syndrome
|
|
Polycystic Ovary Syndrome Overview
|
|
Impaired Osteoblast Function in Gout
|
|
Osteoclast Activation in Gout
|
|
Induction of Apoptosis and Immediate Early Gene Activation in Hippocampal Neurons Following Seizures
|
|
ADK Downregulation after Acute Seizures in Epilepsy
|
|
Regulation of Vascular Reactivity in Raynaud Disease
|
|
Purine metabolism
|
|
ADORA1/2A -> exocytosis
|
|
ADORA2A/B -> vasodilation
|
|
ADRB1/3 -> vasodilation
|
|
ADRA2C/ADRB2 -> vasoconstriction
|
|
ADRB1 -> prostaglandin generation
|
|
ADRA1 -> ion channels
|
|
ADRB1 -> ion channels
|
|
ADRA2C/ADRB2 -> synaptic endocytosis
|
|
ADRA2A -> hyperpolarization
|
|
GABA(B)R -> postsynaptic inhibition
|
|
GRM1/5 (postsynaptic) -> ion channels
|
|
GRM2-4/6-8 (presynaptic) -> glutamate release attenuation
|
|
OPRD/OPRM -> ion channels
|
|
OPRL1 -> ion channels
|
|
P2RY11/13/14 -> IL8/10 production
|
|
BDKRB1/2 -> vasodilation
|
|
BDKRB1/2 -> ion channels
|
|
CGRP -> calcium influx
|
|
CRH -> synthesis of corticosteroids
|
|
HRH1/2 -> membrane polarization
|
|
HRH1/3 -> synaptic transmission
|
|
HRH1/2 -> vascular motility
|
|
HRH2/4 -> IL6/10 production
|
|
PTGDR -> vasodilation
|
|
PTGER1/4 -> vascular motility
|
|
PTGER2/3 -> vascular motility
|
|
PTGIR -> vasodilation
|
|
PTGIR -> IL6 production
|
|
HTR1 -> vascular motility
|
|
HTR4/6/7 -> vasodilation
|
|
HTR7 -> IL6 production
|
|
HTR2 -> membrane transport
|
|
HTR4/6/7 -> cation channels
|
|
CNR1/2 -> membrane transport
|
|
CNR1/2 -> vascular motility
|
|
CNR1/2 -> IL1B/2/4/6/10 production
|
|
DRD2/4 -> membrane transport
|
|
Nociception-related DRD1/5 expression targets
|
|
EDNRA/B -> vascular motility
|
|
CHRM1/2/3/5 -> ion channels
|
|
CHRM1/2/3 -> vascular motility
|
|
CHRNA7 -> NOS1 production
|
|
TACR1 -> membrane transport
|
|
NPY1R -> CRH/POMC production
|
|
TAAR1 -> neurotransmitter uptake
|
|
GALR1/2/3 -> neurotransmitter metabolism
|
|
GALR1/2/3 -> POMC/NPY production
|
|
Regulation of potassium flux
|
|
Regulation of sodium flux
|
|
Summarized nociception-related expression targets
|
|
Summarized vascular motility pathway
|
|
Regulation of calcium flux
|
|
OPRK -> pain perception
|
|
CannabinoidR -> AP-1/EGR signaling
|
|
SomatostatinR -> ATF1/TP53 signaling
|
|
NeuropeptideYR -> ATF/CREB signaling
|
|
PTAFR -> AP-1/ATF1/CREB/ERK-SRF signaling
|
|
GRM1/5 -> CREB signaling
|
|
IL8R -> CREB/EGR signaling
|
|
EndothelinRb -> AP-1/CREB/ELK-SRF signaling
|
|
ProstaglandinIR -> ATF1/ELK-SRF/CREB signaling
|
|
AdrenergicRb -> CREB signaling
|
|
TachykininR -> ELK-SRF signaling
|
|
VIPR -> CREB/CEBP signaling
|
|
AdrenergicRb -> STAT3 signaling
|
|
AngiotensinR -> CREB/ELK-SRF/TP53 signaling
|
|
DopamineR1 -> CREB/ELK-SRF signaling
|
|
SerotoninR4/6/7 -> NR3C signaling
|
|
FSHR -> CREB/ELK-SRF/GATA4 signaling
|
|
VasopressinR2 -> CREB/ELK-SRF/AP-1/EGR signaling
|
|
GlucagonR -> CREB/ELK-SRF/SP1 signaling
|
|
ThromboxaneR -> CREB signaling
|
|
CholinergicRn -> CREB signaling
|
|
Insulin Action
|
|
Melanogenesis
|
|
Guanylate Cyclase Pathway
|
|
Gonadotrope Cell Activation
|
|
Axon Guidance
|
|
Apoptosis Regulation
|
|
Cell Cycle Regulation
|
|
Gap Junction Regulation
|
|
Atlas of Signaling
|
|
Doxorubicin-Induced Cardiotoxicity
|
|
Valdecoxib-Induced Ischemic Disease
|
|
ROS and RNS in the Regulation of Vasoconstriction and Vasodilation
|
|
SST Expression Targets
|
|
NPY Expression Targets
|
|
Dronabinol/Anandamide Expression Targets
|
|
Acetylcholine Expression Targets
|
|
Thromboxane A2 Expression Targets
|
|
Glutamate/Gq Expression Targets
|
|
S1P Expression Targets
|
|
TAC1 Expression Targets
|
|
PGE1 Expression Targets
|
|
Epinephrine/Gs Expression Targets
|
|
Noradrenaline/Gs Expression Targets
|
|
VIP Expression Targets
|
|
Dopamine/Gs Expression Targets
|
|
GCG Expression Targets
|
|
FSHR Expression Targets
|
|
AVP/Gs -> CREB/ELK-SRF/AP-1/EGR Expression Targets
|
|
Serotonin/Gs Expression Targets
|
|
CXCL1 Expression Targets
|
|
CXCL2 Expression Targets
|
|
CXCL3 Expression Targets
|
|
CXCL5 Expression Targets
|
|
CXCL6 Expression Targets
|
|
EDN1 Expression Targets
|
|
EDN3 Expression Targets
|
|
ADCYAP1 Expression Targets
|
|
AGT/TP53 Expression Targets
|
|
AGT/ELK-SRF Expression Targets
|
|
IL1B/PGE2 Expression Targets
|
|
AGT/CREB Expression Targets
|
|
PAF/Gq -> AP-1/ATF1/CREB/ERK-SRF Expression Targets
|
|
dopamine signaling pathway
|
|
protein kinase A (PKA) signaling pathway
|
|
peripheral dopamine signaling pathway
|
|
acetylcholine signaling pathway via muscarinic acetylcholine receptor
|
|
epinephrine signaling pathway via adrenergic receptor beta
|
|
protein kinase A (PKA) signaling pathway
|
|
vasopressin signaling pathway via receptor type 2
|
|
glucagon signaling pathway
|
|
vasopressin signaling pathway - first
|
|
dopamine signaling pathway
|